Latest Manufacturing Efficiency News

Wagners Holding Company Limited reported a solid FY25 with revenue of $431.3 million, driven by growth in construction materials and composite fibre technologies, while reducing net debt by 29%.

Star Combo Pharma Limited reported a 7% increase in total revenue to $27.8 million for FY25, propelled by a 10% rise in its core OEM and Own Brands segment. The company’s profit before tax surged to $5.31 million, reflecting operational strength despite challenges in its Retail division.

thl reports a statutory net loss for FY25, driven by impairments, while underlying profit falls 45%. The company maintains dividends and outlines strategic initiatives to restore growth and profitability.

Amaero Ltd has secured A$50 million through a share placement and plans a further A$3 million via a Share Purchase Plan to fast-track growth initiatives aligned with U.S. defense and manufacturing re-shoring priorities.

VEEM Ltd reported a 15% revenue decline in FY25 amid rising costs and COVID impacts but showed a robust second-half recovery and secured a significant $65 million defence contract renewal.

VEEM Ltd posted a 15% revenue decline and a 57% net profit drop for FY25, reflecting cyclical defence contract impacts. The company secured a $65 million ASC contract extension and continues investing in R&D and automation to drive future growth.

VRX Silica Limited has secured approval for its Mining Proposal at the Arrowsmith North Silica Sand Project, marking a pivotal step toward production in a globally significant silica sand deposit.

Pure Foods Tasmania reports solid progress in its turnaround strategy with significant cost reductions and improved product quality, setting the stage for profitable growth in FY26.

Atomo Diagnostics reports strong commercial momentum in Q4 FY25, highlighted by a major US supply agreement, rapid growth in HIV self-test sales, and promising data for its syphilis test.

ClearVue Technologies and LandGlass subsidiary LandVac have entered a strategic partnership to co-develop and commercialize advanced solar vacuum insulated glazing products, aiming to revolutionize energy-efficient building materials worldwide.

Orthocell Limited has reported a record FY2025 revenue of A$9.19 million, driven by strong sales of its nerve repair product Remplir™ in Australia and a promising US market launch following FDA clearance.

SunRice reported a slight decline in FY25 revenue to $1.85 billion but achieved improved profitability, driven by strategic acquisitions and operational efficiencies. The company is investing in sustainability and capacity upgrades as it pursues its 2030 Growth Strategy.